Grupo de Estudo de Cardio-Oncologia
@GecoSpc
Followers
107
Following
173
Media
29
Statuses
483
GECO's mission is to develop Cardio-Oncology in Portugal, promoting links between centres, postgraduate training and research.
Portugal
Joined September 2022
0
2
3
RT @JulieMcCrossin: Cancer Survivorship: Life After Cancer. Practical guidance on rehabilitation. Link To Video: Re….
0
3
0
RT @JACCJournals: New in #JACCCardioOnc: After hematopoietic stem cell transplant #HSCT, ~1 in 4 patients developed #POTS, and it was linke….
0
11
0
RT @DrRaulCordoba: #Hematology Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With #Hodgkin #Lymphoma | @….
0
2
0
RT @ICOSociety: 🚨NEW PODCAST 🚨 This week on All Things Cardio-Oncology, we're joined by @HassingSara to discuss the latest on the CAUSE (Ca….
0
1
0
RT @escardio: The @ESC_Journals Family will have a new addition at the beginning of 2026 – the European Heart Journal - Cardio-Oncology. Th….
0
16
0
RT @DrRaulCordoba: European Heart Journal @ehjopen .European Society of Cardiology @escardio.COLLECTION.“Advances in Cardio-Oncology”.#….
0
2
0
RT @cardiooncoSEC: 📣 Join us for a special #CardioOncology Networking Event in Madrid!.🇪🇸 Hosted by @cardiooncoSEC , in collaboration with….
0
10
0
RT @ICOSociety: #GCOS25 Abstracts proposals are due in one week! Submit your proposal by July 2nd to share your research in 🇿🇦 South Africa….
0
4
0
RT @ICOSociety: 🚨NEW PODCAST🚨 In February, the Exercise Working Group published an article in the @ESC_Journals on #CORE. We sat down with….
0
3
0
RT @ESC_Journals: Heart-breaking tumours: a case series of malignant pericardial effusion. #EHJCaseReports @Phiso….
0
10
0
RT @JACCJournals: Approx ratios of 0.6 (daunorubicin) & 10.5 (mitoxantrone) to doxorubicin help estimate CTRCD risk-equivalent doses. Data….
0
4
0
RT @LlamedoClara: Look right! Dr. Rosenkranz and a fantastic overview of ca treatment–induced P(A)H.💡 First step: think about it!.💡 #EchoFi….
0
5
0
RT @JACCJournals: Key takeaways from #JACCCardioOnc AE Dr. Alexandra Thomas on risk-guided cardioprotection:. 🛠 Expand cancer-specific risk….
0
3
0
RT @slumberbell: #Ribociclib, a CDK4/6 inhibitor used as adjuvant #breastCA therapy, has recently been reported to cause #cardiotoxicity in….
0
4
0
ACS revascularization in cancer patients.Are you team @mmamas1973 or team @Sofiegevaert?.🇵🇹 @mnobremenezes work highlighted.@spcardio @APIC_pt
0
5
6